TILT Holdings Announces Upcoming Conference Schedule

PHOENIX, Nov. 01, 2022 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, will participate in two conferences in the coming weeks:

  • MJBizCon, Las Vegas, November 15-18, 2022: Chief Executive Officer Gary Santo will participate in a panel titled, “Strengthening Social Equity in Cannabis Through Strategic Partnerships,” from 3:30 to 4:15 p.m. PT on Wednesday, November 16.

  • CannaVest, Las Vegas, November 16-17, 2022: Chief Executive Officer Gary Santo will participate in a panel titled, “Cannabis 3.0 in a Post-Pandemic World,” from 8:45 to 9:30 a.m. PT on Wednesday, November 16.

About TILT

TILT helps cannabis businesses build brands. Through a portfolio of companies providing technology, hardware, cultivation and production, TILT services brands and cannabis retailers across 37 states in the U.S., as well as Canada, Israel, South America and the European Union. TILT’s core businesses include Jupiter Research LLC, a wholly-owned subsidiary and leader in the vaporization segment focused on hardware design, research, development and manufacturing; and cannabis operations, Commonwealth Alternative Care, Inc. in Massachusetts, Standard Farms LLC in Pennsylvania, Standard Farms Ohio, LLC in Ohio, and its partnership with the Shinnecock Indian Nation in New York. TILT is headquartered in Phoenix, Arizona. For more information, visit www.tiltholdings.com.

Company Contact:
Lynn Ricci, VP of Investor Relations & Corporate Communications
TILT Holdings Inc.
lricci@tiltholdings.com

Investor Relations Contact:
Sean Mansouri, CFA
Elevate IR
TILT@elevate-ir.com
720.330.2829

Media Contact:
Leland Radovanovic
Trailblaze
TILT@trailblaze.com


Primary Logo

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.